Efficacy and Safety of Percutaneous Cryoablation for Stage 1A/B Renal Cell Carcinoma: Results of a Prospective, Single-Arm, 5-Year Study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-12

AUTHORS

Christos S. Georgiades, Ron Rodriguez

ABSTRACT

PURPOSE: Percutaneous cryoablation is gaining in popularity as a viable treatment option for renal cell carcinoma (RCC). We present the 5-year oncologic outcomes of a prospective trial. METHODS: Over a 5-year period, we treated 134 consecutive patients with biopsy-proven RCC with CT-guided percutaneous cryoablation. All were treated while under conscious sedation. Technical objective was for the ice ball to cover the lesion plus a 5-mm margin. Hydro- or air dissection was utilized to aid in technical success as needed. Efficacy was defined as the lack of enhancement and/or enlargement of a previously enhancing lesion on follow-up imaging. Safety was assessed by the common terminology criteria for adverse events (CTCAE), version 4.0. RESULTS: The 1-, 2-, 3-, 4-, and 5-year efficacy of percutaneous cryoablation for RCC was 99.2, 99.2, 98.9, 98.5, and 97.0%, respectively. Median tumor size was 2.8 ± 1.4 cm. All-cause mortality during the study period was 3 (none from RCC), yielding an overall 5-year survival of 97.8%. The cancer-specific 5-year survival was 100%. No patient developed metastatic disease during the follow-up period. The overall significant CTCAE version 4.0 complication rate was 6%, with the most frequent being transfusion-requiring hemorrhage, at 1.6%. There was one 30-day mortality unrelated to the procedure. CONCLUSION: CT-guided percutaneous cryoablation for renal cancer offers very high efficacy, approaching that of the gold standard, with a more favorable safety profile. More... »

PAGES

1494-1499

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00270-013-0831-8

DOI

http://dx.doi.org/10.1007/s00270-013-0831-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1007376125

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24385225


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biopsy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Renal Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Conscious Sedation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cryosurgery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Magnetic Resonance Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Safety", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Postoperative Complications", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiography, Interventional", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tomography, X-Ray Computed", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "American Heart Institute", 
          "id": "https://www.grid.ac/institutes/grid.477021.7", 
          "name": [
            "Vascular and Interventional Radiology, American Medical Center, 215 Spyrou Kyprianou Avenue, 2047, Nicosia, Cyprus"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Georgiades", 
        "givenName": "Christos S.", 
        "id": "sg:person.01363511101.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01363511101.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas Health Science Center at San Antonio", 
          "id": "https://www.grid.ac/institutes/grid.267309.9", 
          "name": [
            "Urologic Surgery, University of Texas Health Science Center, 7703 Floyd Curl Drive, 78229, San Antonio, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rodriguez", 
        "givenName": "Ron", 
        "id": "sg:person.01342364426.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342364426.74"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/j.1464-410x.2010.09851.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001477634"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jvir.2012.11.022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002741115"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jvir.2012.11.022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002741115"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007186425"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007186425"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23896", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008627333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.urology.2012.08.055", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009560731"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000333348", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009636128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00270-010-9934-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013229685", 
          "https://doi.org/10.1007/s00270-010-9934-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jso.23071", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016596465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jvir.2011.09.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025221385"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jvir.2011.09.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025221385"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-410x.2010.09788.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046805038"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/end.2006.20.569", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059257460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/end.2009.0328", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059258641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/end.2012.0244", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059259734"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2214/ajr.12.8618", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069302552"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078156603", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078462192", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-12", 
    "datePublishedReg": "2014-12-01", 
    "description": "PURPOSE: Percutaneous cryoablation is gaining in popularity as a viable treatment option for renal cell carcinoma (RCC). We present the 5-year oncologic outcomes of a prospective trial.\nMETHODS: Over a 5-year period, we treated 134 consecutive patients with biopsy-proven RCC with CT-guided percutaneous cryoablation. All were treated while under conscious sedation. Technical objective was for the ice ball to cover the lesion plus a 5-mm margin. Hydro- or air dissection was utilized to aid in technical success as needed. Efficacy was defined as the lack of enhancement and/or enlargement of a previously enhancing lesion on follow-up imaging. Safety was assessed by the common terminology criteria for adverse events (CTCAE), version 4.0.\nRESULTS: The 1-, 2-, 3-, 4-, and 5-year efficacy of percutaneous cryoablation for RCC was 99.2, 99.2, 98.9, 98.5, and 97.0%, respectively. Median tumor size was 2.8 \u00b1 1.4 cm. All-cause mortality during the study period was 3 (none from RCC), yielding an overall 5-year survival of 97.8%. The cancer-specific 5-year survival was 100%. No patient developed metastatic disease during the follow-up period. The overall significant CTCAE version 4.0 complication rate was 6%, with the most frequent being transfusion-requiring hemorrhage, at 1.6%. There was one 30-day mortality unrelated to the procedure.\nCONCLUSION: CT-guided percutaneous cryoablation for renal cancer offers very high efficacy, approaching that of the gold standard, with a more favorable safety profile.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00270-013-0831-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1091062", 
        "issn": [
          "0174-1551", 
          "1432-086X"
        ], 
        "name": "CardioVascular and Interventional Radiology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "37"
      }
    ], 
    "name": "Efficacy and Safety of Percutaneous Cryoablation for Stage 1A/B Renal Cell Carcinoma: Results of a Prospective, Single-Arm, 5-Year Study", 
    "pagination": "1494-1499", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "23228988f50c4f3d37968dee652ce6d34950836c10535f52d5c119f85d324b04"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24385225"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8003538"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00270-013-0831-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1007376125"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00270-013-0831-8", 
      "https://app.dimensions.ai/details/publication/pub.1007376125"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T01:06", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8697_00000510.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00270-013-0831-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00270-013-0831-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00270-013-0831-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00270-013-0831-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00270-013-0831-8'


 

This table displays all metadata directly associated to this object as RDF triples.

202 TRIPLES      21 PREDICATES      64 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00270-013-0831-8 schema:about N23cd37772e8e4453ac76b609ce875f9b
2 N24697b44bf0d4d3da3d011bd48f39290
3 N3410effd88fd4687803dac3f9443a0f1
4 N37c4c22fde0c490a917f9a7dd190c7c8
5 N41cd136f250d42a188fb48a37d34cdc0
6 N579bfacd3ac440698209c630e9f3725b
7 N5972ed6d536b49bcb2289d17c3504834
8 N625161430d724572844944374425978b
9 N896d0d08e3e24bcd8c013f1998139af1
10 N89d53b198ca7430486b7c1948c475c35
11 Na51da207b9324300ab21d7415cffa131
12 Nb837d8abd2e94e2d9b2cf11c66950df3
13 Nbf8b8a869d6f438a834bcdeff06e0930
14 Nc97da5dc157e454f9f178c5a35d2f489
15 Nd932f68917664282bf76db01c4db6b62
16 Ndfbec5ea093843448e45331e60073580
17 Ne7d8120c2fc84bd7b85413fe71994a21
18 Ne95e668ef17c43cc95dac436ea3883b9
19 Nf34975d83df94105a3947d41a4babd6d
20 anzsrc-for:11
21 anzsrc-for:1103
22 schema:author N63d3b1387c3f4147b8056e8fcedb2799
23 schema:citation sg:pub.10.1007/s00270-010-9934-7
24 https://app.dimensions.ai/details/publication/pub.1078156603
25 https://app.dimensions.ai/details/publication/pub.1078462192
26 https://doi.org/10.1002/cncr.23896
27 https://doi.org/10.1002/cncr.25002
28 https://doi.org/10.1002/jso.23071
29 https://doi.org/10.1016/j.jvir.2011.09.008
30 https://doi.org/10.1016/j.jvir.2012.11.022
31 https://doi.org/10.1016/j.urology.2012.08.055
32 https://doi.org/10.1089/end.2006.20.569
33 https://doi.org/10.1089/end.2009.0328
34 https://doi.org/10.1089/end.2012.0244
35 https://doi.org/10.1111/j.1464-410x.2010.09788.x
36 https://doi.org/10.1111/j.1464-410x.2010.09851.x
37 https://doi.org/10.1159/000333348
38 https://doi.org/10.2214/ajr.12.8618
39 schema:datePublished 2014-12
40 schema:datePublishedReg 2014-12-01
41 schema:description PURPOSE: Percutaneous cryoablation is gaining in popularity as a viable treatment option for renal cell carcinoma (RCC). We present the 5-year oncologic outcomes of a prospective trial. METHODS: Over a 5-year period, we treated 134 consecutive patients with biopsy-proven RCC with CT-guided percutaneous cryoablation. All were treated while under conscious sedation. Technical objective was for the ice ball to cover the lesion plus a 5-mm margin. Hydro- or air dissection was utilized to aid in technical success as needed. Efficacy was defined as the lack of enhancement and/or enlargement of a previously enhancing lesion on follow-up imaging. Safety was assessed by the common terminology criteria for adverse events (CTCAE), version 4.0. RESULTS: The 1-, 2-, 3-, 4-, and 5-year efficacy of percutaneous cryoablation for RCC was 99.2, 99.2, 98.9, 98.5, and 97.0%, respectively. Median tumor size was 2.8 ± 1.4 cm. All-cause mortality during the study period was 3 (none from RCC), yielding an overall 5-year survival of 97.8%. The cancer-specific 5-year survival was 100%. No patient developed metastatic disease during the follow-up period. The overall significant CTCAE version 4.0 complication rate was 6%, with the most frequent being transfusion-requiring hemorrhage, at 1.6%. There was one 30-day mortality unrelated to the procedure. CONCLUSION: CT-guided percutaneous cryoablation for renal cancer offers very high efficacy, approaching that of the gold standard, with a more favorable safety profile.
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree false
45 schema:isPartOf N247f4c4575624d4e851ebe3867e72070
46 N45f4553c01864587876571df0301b077
47 sg:journal.1091062
48 schema:name Efficacy and Safety of Percutaneous Cryoablation for Stage 1A/B Renal Cell Carcinoma: Results of a Prospective, Single-Arm, 5-Year Study
49 schema:pagination 1494-1499
50 schema:productId N0b39c77a438847a7a41510c758473c8f
51 N6cb98491a83a42c98983043711cdf4c6
52 N7e4971f9df874103a9a844f3d11d3601
53 N9c1c848a19384855aab3434e21e3c7aa
54 Nefad9d5476e34f4d849c3aafd6ab4863
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007376125
56 https://doi.org/10.1007/s00270-013-0831-8
57 schema:sdDatePublished 2019-04-11T01:06
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher N6d86ba7bdaf442d79d7a71673d76a672
60 schema:url http://link.springer.com/10.1007%2Fs00270-013-0831-8
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N0b39c77a438847a7a41510c758473c8f schema:name readcube_id
65 schema:value 23228988f50c4f3d37968dee652ce6d34950836c10535f52d5c119f85d324b04
66 rdf:type schema:PropertyValue
67 N23cd37772e8e4453ac76b609ce875f9b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Magnetic Resonance Imaging
69 rdf:type schema:DefinedTerm
70 N24697b44bf0d4d3da3d011bd48f39290 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Postoperative Complications
72 rdf:type schema:DefinedTerm
73 N247f4c4575624d4e851ebe3867e72070 schema:issueNumber 6
74 rdf:type schema:PublicationIssue
75 N3410effd88fd4687803dac3f9443a0f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Adult
77 rdf:type schema:DefinedTerm
78 N37c4c22fde0c490a917f9a7dd190c7c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Aged
80 rdf:type schema:DefinedTerm
81 N41cd136f250d42a188fb48a37d34cdc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Humans
83 rdf:type schema:DefinedTerm
84 N45f4553c01864587876571df0301b077 schema:volumeNumber 37
85 rdf:type schema:PublicationVolume
86 N579bfacd3ac440698209c630e9f3725b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Conscious Sedation
88 rdf:type schema:DefinedTerm
89 N5972ed6d536b49bcb2289d17c3504834 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Tomography, X-Ray Computed
91 rdf:type schema:DefinedTerm
92 N625161430d724572844944374425978b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Male
94 rdf:type schema:DefinedTerm
95 N63d3b1387c3f4147b8056e8fcedb2799 rdf:first sg:person.01363511101.27
96 rdf:rest N9e84a65b418f4467953482821477724b
97 N6cb98491a83a42c98983043711cdf4c6 schema:name pubmed_id
98 schema:value 24385225
99 rdf:type schema:PropertyValue
100 N6d86ba7bdaf442d79d7a71673d76a672 schema:name Springer Nature - SN SciGraph project
101 rdf:type schema:Organization
102 N7e4971f9df874103a9a844f3d11d3601 schema:name doi
103 schema:value 10.1007/s00270-013-0831-8
104 rdf:type schema:PropertyValue
105 N896d0d08e3e24bcd8c013f1998139af1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Biopsy
107 rdf:type schema:DefinedTerm
108 N89d53b198ca7430486b7c1948c475c35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Patient Safety
110 rdf:type schema:DefinedTerm
111 N9c1c848a19384855aab3434e21e3c7aa schema:name nlm_unique_id
112 schema:value 8003538
113 rdf:type schema:PropertyValue
114 N9e84a65b418f4467953482821477724b rdf:first sg:person.01342364426.74
115 rdf:rest rdf:nil
116 Na51da207b9324300ab21d7415cffa131 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Radiography, Interventional
118 rdf:type schema:DefinedTerm
119 Nb837d8abd2e94e2d9b2cf11c66950df3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Treatment Outcome
121 rdf:type schema:DefinedTerm
122 Nbf8b8a869d6f438a834bcdeff06e0930 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Kidney Neoplasms
124 rdf:type schema:DefinedTerm
125 Nc97da5dc157e454f9f178c5a35d2f489 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Prospective Studies
127 rdf:type schema:DefinedTerm
128 Nd932f68917664282bf76db01c4db6b62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Cryosurgery
130 rdf:type schema:DefinedTerm
131 Ndfbec5ea093843448e45331e60073580 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Female
133 rdf:type schema:DefinedTerm
134 Ne7d8120c2fc84bd7b85413fe71994a21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Aged, 80 and over
136 rdf:type schema:DefinedTerm
137 Ne95e668ef17c43cc95dac436ea3883b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Carcinoma, Renal Cell
139 rdf:type schema:DefinedTerm
140 Nefad9d5476e34f4d849c3aafd6ab4863 schema:name dimensions_id
141 schema:value pub.1007376125
142 rdf:type schema:PropertyValue
143 Nf34975d83df94105a3947d41a4babd6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Middle Aged
145 rdf:type schema:DefinedTerm
146 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
147 schema:name Medical and Health Sciences
148 rdf:type schema:DefinedTerm
149 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
150 schema:name Clinical Sciences
151 rdf:type schema:DefinedTerm
152 sg:journal.1091062 schema:issn 0174-1551
153 1432-086X
154 schema:name CardioVascular and Interventional Radiology
155 rdf:type schema:Periodical
156 sg:person.01342364426.74 schema:affiliation https://www.grid.ac/institutes/grid.267309.9
157 schema:familyName Rodriguez
158 schema:givenName Ron
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342364426.74
160 rdf:type schema:Person
161 sg:person.01363511101.27 schema:affiliation https://www.grid.ac/institutes/grid.477021.7
162 schema:familyName Georgiades
163 schema:givenName Christos S.
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01363511101.27
165 rdf:type schema:Person
166 sg:pub.10.1007/s00270-010-9934-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013229685
167 https://doi.org/10.1007/s00270-010-9934-7
168 rdf:type schema:CreativeWork
169 https://app.dimensions.ai/details/publication/pub.1078156603 schema:CreativeWork
170 https://app.dimensions.ai/details/publication/pub.1078462192 schema:CreativeWork
171 https://doi.org/10.1002/cncr.23896 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008627333
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1002/cncr.25002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007186425
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1002/jso.23071 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016596465
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1016/j.jvir.2011.09.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025221385
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1016/j.jvir.2012.11.022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002741115
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1016/j.urology.2012.08.055 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009560731
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1089/end.2006.20.569 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059257460
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1089/end.2009.0328 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059258641
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1089/end.2012.0244 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059259734
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1111/j.1464-410x.2010.09788.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1046805038
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1111/j.1464-410x.2010.09851.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1001477634
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1159/000333348 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009636128
194 rdf:type schema:CreativeWork
195 https://doi.org/10.2214/ajr.12.8618 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069302552
196 rdf:type schema:CreativeWork
197 https://www.grid.ac/institutes/grid.267309.9 schema:alternateName The University of Texas Health Science Center at San Antonio
198 schema:name Urologic Surgery, University of Texas Health Science Center, 7703 Floyd Curl Drive, 78229, San Antonio, TX, USA
199 rdf:type schema:Organization
200 https://www.grid.ac/institutes/grid.477021.7 schema:alternateName American Heart Institute
201 schema:name Vascular and Interventional Radiology, American Medical Center, 215 Spyrou Kyprianou Avenue, 2047, Nicosia, Cyprus
202 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...